Triumvira Immunologics Inc. — Form D/A
Triumvira Immunologics Inc. of AUSTIN, TX, a company, filed a Form D amendment with the SEC on 2022-01-07. The offering totals $26.8M, of which $26.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-01-07
- Form: D/A
- Accession: 0001567619-22-000847
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.8M
- Amount sold: $26.8M
- Investors: 10
- Date of first sale: 2021-04-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-398823
Issuer
- Name: Triumvira Immunologics Inc.
- CIK: 0001861332
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Address: 9433 BEE CAVE ROAD, AUSTIN, TX, 78733
- Phone: (201) 882-4550
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| CYNTHIA C COLLINS, MBA | Director | AUSTIN, TX |
| SHAAN C GANDHI, MD, DPhil | Director | AUSTIN, TX |
| SCOTT C SMITH | Director | AUSTIN, TX |
| CYNTHIA M COLLINS, MBA | Director | AUSTIN, TX |
| SCOTT M SMITH | Director | AUSTIN, TX |
| DANIEL C JANSE | Director | AUSTIN, TX |
| JURGEN M ECKHARDT | Director | AUSTIN, TX |
| TERESA C MCROBERTS | Executive Officer | AUSTIN, TX |
| PAUL LAMMERS, MD, MSc | Director | AUSTIN, TX |
| PAUL LAMMERS, MD, MSc | Executive Officer | AUSTIN, TX |
| ELIZABETH C WILLIAMS | Director | AUSTIN, TX |
| JON C IRVIN | Executive Officer | AUSTIN, TX |
| WIDYA M MULYASASMITA | Director | AUSTIN, TX |
| LEE M COOPER | Director | AUSTIN, TX |
| BRIAN M BLOOM | Director | HALIFAX, A5 |
Other filings by this issuer (3)
More